Individuals Coming Off Weight-Loss Injections Put On Weight at a Quadrupled Rate Compared to Those on Conventional Diets

Fresh analysis suggests that individuals who discontinue popular slimming jabs like Mounjaro or Wegovy may regain shed pounds much more quickly than those who halt conventional lifestyle plans.

Findings released in a leading health publication shows that while overweight people often shed a large proportion of their body weight while on the medication, the weight comes back at an average rate of 0.8 kg per month after stopping.

"Users using these treatments need to be cognizant of the danger of rapid rebound weight gain when the medication ends," warns researcher Dr. Susan Jebb.

That rate of recovery suggests a return to starting weight within about one and a half years.

Analyzing Treatments

The analysis, which reviewed 37 of studies involving thousands of participants, contrasted the effects of these new drugs with other pills.

The team point out that people who shed pounds through dieting generally have a slower weight regain—approximately 0.1 kg a month—after stopping.

Explaining the Rapid Regain

Experts suggest the mechanism of the drugs is key to understanding the amplified weight return.

These medications imitate a natural hormone called GLP-1, which moderates hunger.

"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and could diminish responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.

"Withdrawal of this medication results in hunger is uncontrolled, making overeating much more probable."

A Lifelong Disease?

Health authorities advise the jabs for people with weight-linked health risks, alongside prescribed lifestyle changes.

Many experts contend that, considering the significant potential of weight regain, the therapy might need to be ongoing.

This opinion is supported by pharmaceutical companies, who say that the findings "underscore the chronic character of obesity," similar to managing diseases like hypertension.

Patient Accounts

Users who have stopped the jabs describe a powerful resurgence of hunger.

"It was like something activating and I was suddenly starving," recalled a patient.

The struggle is exacerbated if users have not developed permanent lifestyle or habit modifications during treatment.

Significant Adoption

Recent estimates suggest that a significant number of people in the UK have tried weight-loss jabs in the past year, with desire being substantial.

• Use is greater among women than men.
• The 40s and 50s age group shows the greatest level of interest.
• A large proportion access the drugs through private prescriptions rather than the NHS.

Ultimately, researchers emphasize that while these medications are powerful agents for weight loss, they are not a permanent cure and lasting health benefits likely depends on ongoing lifestyle support.